Maury E. Mulligan

7.4k citations

65 papers · 5.7k indexed · 3 hit papers · h-index 36

Impact in

Infectious Diseases top 0.1%
- Clostridium difficile and Clostridium perfringens research
- Antimicrobial Resistance in Staphylococcus
- Viral gastroenteritis research and epidemiology
Critical Care and Intensive Care Medicine top 0.5%
- Nosocomial Infections in ICU

Papers in

Clinical Biochemistry 19
- Bacterial Identification and Susceptibility Testing 19
Infectious Diseases 48
- Clostridium difficile and Clostridium perfringens research 28
- Antimicrobial Resistance in Staphylococcus 21
- Viral gastroenteritis research and epidemiology 9

Co-authors: Lynne V. McFarland R Y Kwok Walter E. Stamm Dale N. Gerding Lance R. Peterson Stuart Johnson Joseph Silva Gary W. Elmer
Journals: Clinical Infectious Diseases (16 papers)Journal of Clinical Microbiology (10 papers)Infection Control and Hospital Epidemiology (7 papers)Antimicrobial Agents and Chemotherapy (6 papers)The American Journal of Medicine (4 papers)
Partner nations: United States United Kingdom Australia

In The Last Decade

Maury E. Mulligan

65 papers receiving 5.3k citations

Hit Papers

align trajectories log scale

Clostridium Difficile-Associated Diarrhea and Colitis 1995 · 509 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

1995 Infection Control and Hospital Epidemiology
1993 The American Journal of Medicine
1989 New England Journal of Medicine

Peers

Countries citing papers authored by Maury E. Mulligan

Since Specialization

Citations

This map shows the geographic impact of Maury E. Mulligan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maury E. Mulligan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maury E. Mulligan more than expected).

Fields of papers citing papers by Maury E. Mulligan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maury E. Mulligan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maury E. Mulligan. The network helps show where Maury E. Mulligan may publish in the future.

Co-authors

The 25 scholars most cited alongside Maury E. Mulligan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Maury E. Mulligan Line = papers co-authored together Maury E. Mulligan links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	An Episodic Outbreak of Genetically RelatedBurkholdebja cepaciaAmong Non-Cystic Fibrosis Patients at a University Hospital Infection Control and Hospital Epidemiology ·Eunike Dina Awola, Maury E. Mulligan, Eshwar Mahenthiralingam, Joan Hebden, Seung-Uk Kim, Sadaf Qaiyumi, Judith A. Johnson, John J. LiPuma	2001	46
2	The Search for a Better Treatment for RecurrentClostridium difficileDisease: Use of High‐Dose Vancomycin Combined withSaccharomyces boulardii Clinical Infectious Diseases ·Christina M. Surawicz, Lynne V. McFarland, Richard N. Greenberg, Moshe Rubin, Robert Fekety, Maury E. Mulligan, Weal. Otaif., A. Salazar, Karen Bowen, Benedetto Gorini, Gary W. Elmer	2000	394
3	The In Vitro Efficacy of Varidase Versus Streptokinase or Urokinase for Liquefying Thick Purulent Exudative Material from Loculated Empyema Lung ·R.W. Light, Elicia K. Bowman, Maury E. Mulligan, Scott A. Sasse	2000	65
4	Possible role of cross-transmission between neonates and mothers with recurrent Clostridium difficile infections American Journal of Infection Control ·Lynne V. McFarland, Christina M. Surawicz, Richard N. Greenberg, Karen Bowen, L Vanden Brande, Maury E. Mulligan	1999	15
5	Immunoblot Characterization ofPorphyromonasSpecies from Infected Dog and Cat Bite Wounds in Humans Clinical Infectious Diseases ·Maury E. Mulligan, D. M. Citron, R Y Kwok, Ellie J. C. Goldstein	1997	3
6	Serial Pleural Fluid Analysis in a New Experimental Model of Empyema CHEST Journal ·Scott A. Sasse, Olesia Isayuk, Maury E. Mulligan, Richard W. Light	1996	47
7	Clostridium Difficile-Associated Diarrhea and Colitis Infection Control and Hospital Epidemiology ·Dale N. Gerding, Stuart Johnson, Lance R. Peterson, Maury E. Mulligan, Joseph Silva Hit paper breakdown →	1995	509
8	Ventriculoperitoneal Shunt Infection Due to Anaerobic and Facultative Bacteria: Case Report Clinical Infectious Diseases ·W H Close, Maury E. Mulligan	1995	3
9	Mycobacterium genavense Infection Presenting as a Solitary Brain Mass in a Patient with AIDS: Case Report and Review Clinical Infectious Diseases ·Stephen Berman, Lesia Turner, bibblefree, Maury E. Mulligan, Joshua Fierer, Calum Patel	1994	21
10	Nasal Colonization with Methicillin-Resistant Staphylococcus aureus on Admission to the Surgical Intensive Care Unit Increases the Risk of Infection Anesthesia & Analgesia ·Douglas Mest, David H. Wong, 昌宏西原, Maury E. Mulligan, Samuel E. Wilson	1994	94
11	Elevated Levels of Serum Immunoglobulins in Asymptomatic Carriers of Clostridium difficile Clinical Infectious Diseases ·Maury E. Mulligan, Christophe Cordier, Lynne V. McFarland, Henry C. Fung, R Y Kwok	1993	84
12	Bacterial Adhesins and Host Factors: Role in the Development and Outcome of Escherichia coli Bacteremia Clinical Infectious Diseases ·Joel N. Maslow, Maury E. Mulligan, Mr. G. Praveen Kumar, T.L. Markova, R D Arbeit	1993	44
13	Methicillin-resistant Staphylococcus aureus: A consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management The American Journal of Medicine ·Maury E. Mulligan, Alia Bandagi, Bruce S. Ribner, Harold C. Standiford, Joseph F. John, Joyce A. Korvick, Carol A. Kauffman, Victor L. Yu Hit paper breakdown →	1993	542
14	Management and epidemiologic analyses of an outbreak due to methicillin-resistant Staphylococcus aureus The American Journal of Medicine ·Matthew Bidwell Goetz, Maury E. Mulligan, R Y Kwok, Helen O’Brien, Fang Lin, C.K. Choy	1992	42
15	Epidemiologic and Clinical Utility of Typing Systems for Differentiating Among Strains of Methicillin-Resistant Staphylococcus aureus Infection Control and Hospital Epidemiology ·Maury E. Mulligan, Robert D. Arbeit	1991	74
16	Correlation of immunoblot type, enterotoxin production, and cytotoxin production with clinical manifestations of Clostridium difficile infection in a cohort of hospitalized patients Infection and Immunity ·Lynne V. McFarland, Gary W. Elmer, Walter E. Stamm, Maury E. Mulligan	1991	63
17	Response of HIV-associated disseminated cat scratch disease to treatment with doxycycline The American Journal of Medicine ·Guo Tie-zhu, Maury E. Mulligan, W. Lance George	1990	18
18	Nosocomial Acquisition ofClostridium difficileInfection New England Journal of Medicine ·Lynne V. McFarland, Maury E. Mulligan, R Y Kwok, Walter E. Stamm Hit paper breakdown →	1989	1041
19	Clostridium difficile plasmid isolation as an epidemiologic tool European Journal of Clinical Microbiology & Infectious Diseases ·Connie Clabots, Montes Castillo, Dale N. Gerding, Maury E. Mulligan, R Y Kwok, Dennis R. Schaberg, Robert Fekety, Lance R. Peterson	1988	15
20	In vitro activity of novobiocin and rifampin alone and in combination against oxacillin-resistant Staphylococcus aureus Diagnostic Microbiology and Infectious Disease ·Nurhan Aydın, R Y Kwok, Maury E. Mulligan	1987	7

About Maury E. Mulligan

Maury E. Mulligan is a scholar working on Clinical Biochemistry, Infectious Diseases, Molecular Medicine, Endocrinology and Critical Care and Intensive Care Medicine, having authored 65 papers that have together received 5.7k indexed citations. Recurring topics across this work include Clostridium difficile and Clostridium perfringens research (28 papers), Antimicrobial Resistance in Staphylococcus (21 papers), Bacterial Identification and Susceptibility Testing (19 papers), Microscopic Colitis (11 papers), Streptococcal Infections and Treatments (10 papers), Viral gastroenteritis research and epidemiology (9 papers), Antibiotic Resistance in Bacteria (7 papers) and Nosocomial Infections in ICU (7 papers). The work is most often cited by research in Infectious Diseases (4.4k citations), Critical Care and Intensive Care Medicine (870 citations), Clinical Biochemistry (885 citations), Applied Microbiology and Biotechnology (161 citations) and Epidemiology (2.6k citations). Maury E. Mulligan has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Lynne V. McFarland, R Y Kwok, Walter E. Stamm, Dale N. Gerding, Lance R. Peterson, Stuart Johnson, Joseph Silva, Gary W. Elmer, Christina M. Surawicz and Robert Fekety. Their work appears in journals such as Clinical Infectious Diseases, Journal of Clinical Microbiology, Infection Control and Hospital Epidemiology, Antimicrobial Agents and Chemotherapy and The American Journal of Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact